申请人:Eisai R&D Management Co., Ltd.
公开号:EP1777218A1
公开(公告)日:2007-04-25
The present invention concerns a process for preparing a compound represented by the following general formula (a-11):
or a pharmacologically acceptable salt or hydrate thereof, which comprises reacting a compound represented by the following general formula (a-12):
with a compound represented by the following general formula (a-4) :
wherein the residues R1, R2, Rsa1 - Rsa3, R300, R301 and Z are as defined in the claims.
本发明涉及一种制备由以下通式(a-11)代表的化合物的工艺:
或其药理学上可接受的盐或水合物的制备工艺,该工艺包括使下式通式(a-12)所代表的化合物反应:
与下式通式(a-4)所代表的化合物反应:
其中残基 R1、R2、Rsa1-Rsa3、R300、R301 和 Z 如权利要求中所定义。